PNOC022 A Combination Therapy Trial using an Adaptive Platform Design for Children and Young Adults with Diffuse Midline Gliomas (DMGs) including Diffuse Intrinsic Pontine Gliomas (DIPGs) at Initial D
Clinical Trial Grant
Administered By
Duke Cancer Institute
Awarded By
The Regents of the University of California
Start Date
September 13, 2022
End Date
February 13, 2023
Administered By
Duke Cancer Institute
Awarded By
The Regents of the University of California
Start Date
September 13, 2022
End Date
February 13, 2023